Dr. Nima Ramezan Arab, M.D

NPI: 1699705772
Total Payments
$6,841
2024 Payments
$1,441
Companies
48
Transactions
335
Medicare Patients
3,971
Medicare Billing
$611,302

Payment Breakdown by Category

Food & Beverage$6,750 (98.7%)
Education$73.34 (1.1%)
Other$18.04 (0.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,750 331 98.7%
Education $73.34 3 1.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18.04 1 0.3%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $776.86 54 $0 (2024)
ABBVIE INC. $742.97 46 $0 (2024)
UCB, Inc. $557.33 18 $0 (2024)
Neurocrine Biosciences, Inc. $405.21 22 $0 (2024)
Biogen, Inc. $398.97 13 $0 (2024)
Alexion Pharmaceuticals, Inc. $396.56 19 $0 (2024)
SK Life Science, Inc. $296.83 12 $0 (2024)
Genentech USA, Inc. $294.26 12 $0 (2024)
Allergan, Inc. $285.97 13 $0 (2022)
PFIZER INC. $262.35 13 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,441 66 PFIZER INC. ($239.06)
2023 $1,359 59 SK Life Science, Inc. ($169.08)
2022 $1,193 72 ABBVIE INC. ($307.39)
2021 $1,123 63 AbbVie Inc. ($177.94)
2020 $405.87 20 Allergan, Inc. ($90.97)
2019 $619.46 23 Biogen, Inc. ($123.57)
2018 $216.44 12 Medtronic USA, Inc. ($55.10)
2017 $482.41 20 UCB, Inc. ($179.07)

All Payment Transactions

335 individual payment records from CMS Open Payments — Page 13 of 14

Date Company Product Nature Form Amount Type
03/12/2019 Novartis Pharmaceuticals Corporation AIMOVIG (Biological) Food and Beverage In-kind items and services $22.49 General
Category: NEUROSCIENCE
03/11/2019 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $25.00 General
Category: Neuroscience
02/08/2019 Janssen Scientific Affairs, LLC XARELTO (Drug) Food and Beverage In-kind items and services $47.83 General
Category: Cardiovascular & Metabolism
12/13/2018 Medtronic Vascular, Inc. Reveal LINQ (Device) Food and Beverage In-kind items and services $15.88 General
Category: Cardiac Diagnostics and Monitoring
12/05/2018 Impax Laboratories, Inc. RYTARY (Drug) Food and Beverage In-kind items and services $16.39 General
Category: NEUROLOGY
11/16/2018 Genentech USA, Inc. OCREVUS (Biological) Food and Beverage In-kind items and services $13.41 General
Category: Immunology
08/08/2018 Genentech USA, Inc. OCREVUS (Biological) Food and Beverage In-kind items and services $24.45 General
Category: Immunology
08/08/2018 Medtronic USA, Inc. Solitaire (Device) Food and Beverage In-kind items and services $15.37 General
Category: Stents
07/10/2018 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.14 General
Category: Cardiovascular & Metabolism
05/23/2018 Medtronic USA, Inc. Solitaire (Device) Food and Beverage In-kind items and services $24.12 General
Category: Stents
03/21/2018 Medtronic USA, Inc. Solitaire (Device) Food and Beverage In-kind items and services $15.61 General
Category: Stents
03/12/2018 Biogen, Inc. TYSABRI (Biological), TECFIDERA Food and Beverage In-kind items and services $17.68 General
Category: NEUROLOGY
03/08/2018 Allergan Inc. BOTOX THERAPEUTIC (Biological) Food and Beverage In-kind items and services $14.52 General
Category: HYPERHYDROSIS
03/02/2018 Eisai Inc. Fycompa (Drug) Food and Beverage Cash or cash equivalent $24.66 General
Category: Neurology
01/08/2018 Genentech USA, Inc. OCREVUS (Biological) Food and Beverage In-kind items and services $12.21 General
Category: Immunology
12/15/2017 Allergan Inc. BOTOX THERAPEUTIC (Biological) Food and Beverage In-kind items and services $21.40 General
Category: HYPERHYDROSIS
12/07/2017 UCB, Inc. Vimpat (Drug) Food and Beverage In-kind items and services $36.83 General
Category: Neurology
11/27/2017 Genentech USA, Inc. OCREVUS (Biological) Food and Beverage In-kind items and services $23.33 General
Category: Immunology
10/17/2017 Allergan Inc. BOTOX CHRONIC MIGRAINE (Drug) Food and Beverage In-kind items and services $23.84 General
Category: ANTI-MIGRAINE
10/10/2017 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.14 General
Category: Cardiovascular & Metabolism
10/04/2017 Genentech USA, Inc. OCREVUS (Biological) Food and Beverage In-kind items and services $23.64 General
Category: Immunology
09/07/2017 Allergan Inc. BOTOX NEURO REHAB (Drug) Food and Beverage In-kind items and services $23.50 General
Category: NEUROSCIENCE
09/05/2017 UCB, Inc. Vimpat (Drug) Food and Beverage In-kind items and services $41.65 General
Category: Neurology
08/08/2017 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $3.06 General
Category: Neurology
08/07/2017 UCB, Inc. Briviact (Drug) Food and Beverage In-kind items and services $30.99 General
Category: Neurology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 1,148 1,874 $467,312 $186,689
2022 14 1,043 1,590 $403,971 $158,788
2021 12 905 1,375 $324,966 $131,730
2020 15 875 5,863 $348,963 $134,095
Total Patients
3,971
Total Services
10,702
Medicare Billing
$611,302
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 216 566 $128,063 $57,305 44.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 174 300 $72,000 $29,347 40.8%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 198 361 $57,031 $24,177 42.4%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 162 166 $73,030 $22,495 30.8%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 97 138 $44,480 $19,604 44.1%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2023 140 155 $18,414 $7,308 39.7%
99291 Critical care, first 30-74 minutes Facility 2023 22 36 $21,670 $6,204 28.6%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2023 33 33 $15,040 $5,997 39.9%
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes Facility 2023 56 56 $16,578 $5,575 33.6%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2023 14 22 $9,512 $3,865 40.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 24 24 $8,724 $3,510 40.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 12 17 $2,771 $1,300 46.9%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 171 409 $92,540 $35,505 38.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 172 276 $66,240 $28,676 43.3%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 120 123 $54,113 $19,783 36.6%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 164 318 $50,238 $19,196 38.2%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 76 90 $29,009 $13,613 46.9%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 76 76 $22,499 $8,499 37.8%
99205 New patient office or other outpatient visit, 60-74 minutes Office 2022 49 49 $22,332 $8,476 38.0%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 49 49 $17,811 $6,727 37.8%
95816 Measurement of brain wave activity (eeg), awake and drowsy Facility 2022 85 88 $10,454 $4,327 41.4%
95720 Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional Facility 2022 13 24 $10,377 $4,261 41.1%
99291 Critical care, first 30-74 minutes Facility 2022 13 20 $12,039 $3,533 29.3%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Office 2022 25 38 $8,011 $3,233 40.4%
95909 Nerve conduction, 5-6 studies Office 2022 14 14 $4,853 $1,628 33.5%

About Dr. Nima Ramezan Arab, M.D

Dr. Nima Ramezan Arab, M.D is a Neurology healthcare provider based in Los Alamitos, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699705772.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nima Ramezan Arab, M.D has received a total of $6,841 in payments from pharmaceutical and medical device companies, with $1,441 received in 2024. These payments were reported across 335 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,750).

As a Medicare-enrolled provider, Ramezan Arab has provided services to 3,971 Medicare beneficiaries, totaling 10,702 services with total Medicare billing of $611,302. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Location Los Alamitos, CA
  • Active Since 07/04/2006
  • Last Updated 02/19/2017
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1699705772

Products in Payments

  • KESIMPTA (Drug) $700.17
  • NURTEC ODT (Drug) $523.90
  • UBRELVY (Drug) $395.51
  • INGREZZA (Drug) $324.45
  • BOTOX (Biological) $284.49
  • QULIPTA (Drug) $223.56
  • TYSABRI (Biological) $213.78
  • Briviact (Drug) $209.33
  • ULTOMIRIS (Biological) $201.78
  • OCREVUS (Biological) $139.97
  • ZEPOSIA (Drug) $136.29
  • AJOVY (Biological) $128.59
  • BRILINTA (Drug) $124.98
  • NUPLAZID (Drug) $124.17
  • Vimpat (Drug) $115.56
  • XARELTO (Drug) $108.80
  • EMGALITY (Drug) $102.78
  • Ocrevus (Biological) $91.55
  • Aimovig (Biological) $87.78
  • SOLIRIS (Biological) $82.98

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Los Alamitos